文献速递关节外科

定制三翼髋臼组件用于灾难性骨缺损:至少5年结果

Custom Triflange Acetabular Components For Catastrophic Bone Loss: Minimum 5-Year Results.
PubMed 文献 · J Arthroplasty · 2023-01-25

研究纳入2003年8月至2016年7月间64例(66髋)因灾难性骨缺损接受定制三翼髋臼组件重建的全髋关节置换患者,所有髋均为Paprosky 3B或3C。46例(47髋)完成至少5年随访,平均随访8年,因感染行三翼组件翻修3例(6.4%),以任何原因移除三翼组件为终点的生存率为94.1%(95%CI ±3.4%),平均16年。Harris髋关节评分从术前平均41分显著提高至术后64分。

要点

  • 定制三翼髋臼组件用于Paprosky 3B或3C灾难性骨缺损,平均16年以移除为终点的生存率94.1%(95%CI ±3.4%)。
  • 47髋至少5年随访中,因感染行三翼组件翻修3例(6.4%)。
  • Harris髋关节评分从术前平均41分显著提高至术后64分。

核心结论

  • 定制三翼髋臼组件是外科医生武器库中高效的工具,对处理灾难性骨缺损极有帮助,平均16年生存良好。

研究设计与样本

  • 回顾性分析2003年8月至2016年7月间64例(66髋)接受定制三翼髋臼组件行髋臼重建的患者,所有髋均为Paprosky 3B或3C,采用生存分析确定总体生存率。

主要发现

  • 17例(18髋)在返回5年随访前死亡,1例推定存活患者失访,最终46例(47髋)完成至少5年随访;平均年龄65岁(范围46至85),平均体重指数29.4(范围18至45),72%为女性,平均随访8年(范围5至16)。
  • 47髋中因感染行三翼组件翻修3例(6.4%)。
  • 以任何原因移除三翼组件为终点的生存率为94.1%(95%置信区间:±3.4%),平均16年。
  • 总体系列(n=66)中另有9例(13.6%)再次手术:5例切口清创、1例切开复位内固定、2例因假体周围股骨骨折行股骨柄翻修、1例股骨头翻修。
  • Harris髋关节评分从术前平均41分显著提高至术后平均64分。

局限性

  • 17例(18髋)在返回5年随访前死亡,1例推定存活患者失访,最终仅46例(47髋)完成至少5年随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Custom acetabular components are an increasingly utilized reconstructive option in total hip arthroplasty for catastrophic bone loss and acetabular failure. The purpose of this study was to determine the survivorship of such components for reconstruction due to catastrophic bone loss at a minimum 5-year follow-up. METHODS: From August 2003 to July 2016, 64 patients (66 hips) underwent acetabular reconstruction with custom triflange components. All hips were classified as Paprosky 3B or 3C. Harris hip scores were analyzed. Overall survivorship was determined by survival analysis. RESULTS: Seventeen patients (18 hips) died prior to returning for 5-year follow-up. One presumed living patient was lost to contact, yielding a cohort of 46 patients (47 hips) who had minimum 5-year follow-up. The mean age was 65 years (range, 46 to 85), mean body mass index was 29.4 (range, 18 to 45), and 72% were women. Mean follow-up was 8 years (range, 5 to 16). There were 3 revisions of the triflange device (6.4%) due to infection. Survivorship to end point of triflange removal for any reason was 94.1% (95% confidence interval: ±3.4%) at a mean of 16 years. In the overall series (n = 66), there were 9 (13.6%) additional reoperations as follows: 5 incision and debridements, one open reduction internal fixation, two stem revisions for periprosthetic femoral fracture, and one head revision. Harris hip scores improved significantly from a mean of 41 points preoperatively to 64 points postoperatively. CONCLUSIONS: Custom acetabular triflange components represent a highly effective tool in a surgeon's armamentarium. These devices are extremely helpful in managing catastrophic bone loss and have a good mean 16-year survival.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Alexander JS, Lombardi AV, Berend KR, et al. Custom Triflange Acetabular Components For Catastrophic Bone Loss: Minimum 5-Year Results. J Arthroplasty. 2023. PMID: 36708935. doi:10.1016/j.arth.2023.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。